References
- Haldas J, Wang W, Lazarchick J. Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant. Leuk Lymphoma 2002; 43: 447–450
- Nalesnik M A. Clinicopathologic characteristics of post- transplant lymphoproliferative disorders. Recent Results Cancer Res 2002; 159: 9–18
- Draoua H Y, Tsao L, Mancini D M, Addonizio L J, Bhagat G, Alobeid B. T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: A single institutional experience. Br J Haematol 2004; 127: 429–432
- Audouin J, Le Tourneau A, Diebold J, Reynes M, Tabbah I, Bernadou A. Primary intestinal lymphoma of ki-1 large cell anaplastic type with mesenteric lymph node and spleen involvement in a renal transplant recipient. Hematol Oncol 1989; 7: 441–449
- Borisch B, Hennig I, Horber F, Burki K, Laissue J. Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch A Pathol Anat Histopathol 1992; 421: 443–447
- van Gorp J, Doornewaard H, Verdonck L F, Klopping C, Vos P F, van den Tweel J G. Posttransplant T-cell lymphoma. Report of three cases and a review of the literature. Cancer 1994; 73: 3064–3072
- Dockrell D H, Strickler J G, Paya C V. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clin Infect Dis 1998; 26: 180–182
- Frias C, Lauzurica R, Vaquero M, Ribera J M. Detection of Epstein-Barr virus in posttransplantation T cell lymphoma in a kidney transplant recipient: Case report and review. Clin Infect Dis 2000; 30: 576–578
- Hoshida Y, Li T, Dong Z, Tomita Y, Yamauchi A, Hanai J, Aozasa K. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001; 91: 869–875
- Michael J, Greenstein S, Schechner R, Tellis V, Vasovic L V, Ratech H, Glicklich D. Primary intestinal posttransplant T-cell lymphoma. Transplantation 2003; 75: 2131–2132
- E S Jaffe, Harris, N L, Stein, H, Vardiman, J W. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. LyonFrance, IARC Press. 2001, pp 47 – 73.
- Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101–1103
- Gao S Z, Chaparro S V, Perlroth M, Montoya J G, Miller J L, DiMiceli S, Hastie T, Oyer P E, Schroeder J. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant 2003; 22: 505–514
- Hanson M N, Morrison V A, Peterson B A, Stieglbauer K T, Kubic V L, McCormick S R, McGlennen R C, Manivel J C, Brunning R D, Litz C E. Posttransplant T-cell lymphoproliferative disorders—an aggressive, late complication of solid-organ transplantation. Blood 1996; 88: 3626–3633
- Ambinder R F. Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy. Curr Oncol Rep 2003; 5: 359–363
- Davis J E, Moss D J. Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies. Tissue Antigens 2004; 63: 285–292
- Jones J F, Shurin S, Abramowsky C, Tubbs R R, Sciotto C G, Wahl R, Sands J, Gottman D, Katz B Z, Sklar J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318: 733–741